A new weight loss pill, Effexor, could help the billions of people who struggle with obesity, researchers say
NEW YORK — A new weight-loss pill, called Effexo, could reduce the number of people in the U.S. who struggle to lose weight by millions of people.
Researchers at Columbia University and New York University’s Langone Medical Center analyzed data from the National Health and Nutrition Examination Survey and found that more than 10 million people worldwide, mostly in the developing world, are on Effexobas prescription.
The study, published in the Journal of the American Medical Association, says Effexos pills can help people lose at least 5 percent of their body weight over six weeks.
Effexofacin, an oral medication, is the most widely used weight-management drug in the world, and Effexas drug is used for the treatment of diabetes and heart disease.
Researchers say that Effexors ability to help millions of adults around the world to lose more weight could help save the planet and the economy.
EffEXor is being developed by the National Institutes of Health and will be released in July.
The National Institutes for Health and the U